Uptravi 800mcg-TU (Selexipag Tablet) 800 mcg

Uptravi 800mcg-TU (Selexipag) is a prescription tablet used to treat pulmonary arterial hypertension. This 800 mcg strength medication helps manage symptoms by supporting blood flow in the lungs. Ideal for long-term therapy under medical supervision.

Strength

800 mcg

Pack Size

60s

Storage

Ambient

Manufacturer / TM Owner

JOHNSON AND JOHNSON

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Selexipag, the active ingredient in Uptravi 800mcg-TU, is used to treat pulmonary arterial hypertension (PAH). It helps improve exercise capacity and reduce symptoms like shortness of breath. This medication works by relaxing blood vessels in the lungs to enhance blood flow. Patients often use it as part of a broader treatment plan for PAH.

Side Effects

Uptravi 800mcg-TU may cause mild to moderate side effects such as headache, jaw pain, or flushing. Some users report nausea or diarrhea, which are usually temporary. These effects often lessen as the body adjusts to the medication. Staying hydrated and taking doses with food can help minimize discomfort.

Precautions & Warnings

Store Uptravi 800mcg-TU at room temperature away from moisture and heat. Keep the medication in its original packaging to protect it from light. Do not use expired tablets or those that appear damaged. Always check with a healthcare provider before starting or stopping this medication.

Avoid Interactions

Uptravi 800mcg-TU can interact with certain medications, including strong CYP2C8 inhibitors like gemfibrozil. Combining it with blood pressure drugs may increase the risk of low blood pressure. Alcohol and grapefruit products might also affect how the medication works. Always inform your doctor about all medications and supplements you are taking.

Frequently Asked Questions

Uptravi 800mcg-TU is used to treat pulmonary arterial hypertension by improving blood flow in the lungs.

Store the tablets at room temperature, away from moisture, heat, and direct light in the original packaging.

Yes, taking the tablet with food may help reduce nausea or stomach discomfort.

Common side effects include headache, jaw pain, flushing, nausea, or diarrhea, which are usually temporary.

Yes, it can interact with CYP2C8 inhibitors, blood pressure drugs, alcohol, and grapefruit products.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.